{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:42:24Z","timestamp":1787506944267,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019084","name":"Kobe University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.atherosclerosis.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T21:16:51Z","timestamp":1683235011000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The relationship between unique gut microbiome-derived lipid metabolites and subsequent revascularization in patients who underwent percutaneous coronary intervention"],"prefix":"10.1016","volume":"375","author":[{"given":"Daichi","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kawamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Toba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Hamana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Osumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenobu","family":"Kishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9953-0551","authenticated-orcid":false,"given":"Hiromasa","family":"Otake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.5551\/jat.32672","article-title":"Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease","volume":"23","author":"Emoto","year":"2016","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00380-016-0841-y","article-title":"Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease","volume":"32","author":"Emoto","year":"2017","journal-title":"Heart Ves."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.1237439","article-title":"The long-term stability of the human gut microbiota","volume":"341","author":"Faith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","article-title":"Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis","volume":"138","author":"Yoshida","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"17808","DOI":"10.1073\/pnas.1312937110","article-title":"Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition","volume":"110","author":"Kishino","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bbrc.2015.02.154","article-title":"10-oxo-12(Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, potently activates PPARgamma and stimulates adipogenesis","volume":"459","author":"Goto","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2016.02.012","article-title":"10-Oxo-trans-11-octadecenoic acid generated from linoleic acid by a gut lactic acid bacterium Lactobacillus plantarum is cytoprotective against oxidative stress","volume":"296","author":"Furumoto","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib12","first-page":"61","article-title":"Synthesized enone fatty acids resembling metabolites from gut microbiota suppress macrophage-mediated inflammation in adipocytes","author":"Yang","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s11745-015-4067-z","article-title":"Gut microbial fatty acid metabolites reduce triacylglycerol levels in hepatocytes","volume":"50","author":"Nanthirudjanar","year":"2015","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib14","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41467-019-11978-0","article-title":"Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids","volume":"10","author":"Miyamoto","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"C39","DOI":"10.1152\/ajpcell.00024.2014","article-title":"Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue","volume":"307","author":"Colas","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13154-0","article-title":"Novel mechanism of regulation of the 5-lipoxygenase\/leukotriene B4 pathway by high-density lipoprotein in macrophages","volume":"7","author":"Tsuda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10654-011-9567-4","article-title":"PredictABEL: an R package for the assessment of risk prediction models","volume":"26","author":"Kundu","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3389\/fphar.2019.01360","article-title":"Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.bbalip.2007.04.021","article-title":"PPARalpha in atherosclerosis and inflammation","volume":"1771","author":"Zandbergen","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6404638","article-title":"PPARgamma and its role in cardiovascular diseases","volume":"2017","author":"Chandra","year":"2017","journal-title":"PPAR Res."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib26","first-page":"11","article-title":"Targeting IL-1\u03b2 in the treatment of atherosclerosis","author":"Mai","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/01.ATV.0000037100.44766.5B","article-title":"Inflammation and restenosis in the stent era","volume":"22","author":"Welt","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib29","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1096\/fj.14-265363","article-title":"Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice","volume":"29","author":"Akagi","year":"2015","journal-title":"Faseb. J."},{"key":"10.1016\/j.atherosclerosis.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"L746","DOI":"10.1152\/ajplung.00166.2014","article-title":"Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1","volume":"307","author":"Shinohara","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023001843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023001843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:51:31Z","timestamp":1758156691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023001843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":30,"alternative-id":["S0021915023001843"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.05.001","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between unique gut microbiome-derived lipid metabolites and subsequent revascularization in patients who underwent percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}